Search

everythinglearnresearchcommunity

for

Search:↓

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Leydig cells can cause testosterone-secreting adrenal tumors in women.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Hirsutism causes significant psychological distress in women.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.